TwoStep Therapeutics is a biotechnology company developing targeted therapeutics for solid tumors using a polyspecific integrin-binding peptide (PIP) delivery platform. The PIP agent selectively binds multiple tumor-associated integrins, enabling broad applicability across many solid tumor types while minimizing exposure to healthy tissue. The platform is modular and modality-agnostic, with tunable pharmacokinetics and compatibility with diverse therapeutic payloads. The company’s initial therapeutic focus is on targeted cytotoxic drug delivery and immunotherapy. TwoStep launched following a seed financing and was formed by scientist-founders affiliated with Stanford University, including Nobel Laureate Carolyn Bertozzi, Jennifer Cochran, Ronald Levy, and CEO Caitlyn Miller. TwoStep emerged from Stanford’s Innovative Medicines Accelerator and is based in Palo Alto, California.

Total raised

$7M

Funding rounds

1

Latest round

Seed

Latest activity

Jun 2024